Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study looking at how often people being treated for myeloma have a very low number of white blood cells
This study looked at how often people being treated with lenalidomide and dexamethasone for myeloma have a very low number of white blood cells (neutropenia).
More about this trial
- how many people had a drop in white blood cells
- how doctors usually treat it
Summary of results
- 62 people (31%) had a low white blood cell count at least once during treatment
- half of these people had a low white blood cell count 3 times or more
- the drop in white blood cells usually happened about 2 months (8.8 weeks) after starting treatment
- whose kidneys didn’t work as well as normal
- whose myeloma was more advanced
- who were generally less fit and well
- who had other medical conditions
How to join a clinical trial